Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Breast ; 32: 37-43, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28033508

RESUMEN

CONTEXT: Even if neoadjuvant chemotherapy (NACT) and oncoplastic techniques have increased the breast conserving surgery rate, mastectomy is still a standard for multifocal or extensive breast cancers (BC). In the prospect of increasing breast reconstruction, an alternative therapeutic protocol was developed combining NACT with neoadjuvant radiation therapy (NART), followed by mastectomy with immediate breast reconstruction (IBR). The oncological safety of this therapeutic plan still needs further exploration. We assessed pathological complete response (pCR) as a surrogate endpoint for disease free survival. METHODS: Between 2010 and 2016, 103 patients undergoing mastectomy after NACT and NART were recruited. After CT and RT were administrated, a completion mastectomy with IBR by latissimus dorsi flap was achieved 6 to 8 weeks later. pCR was defined by the absence of residual invasive disease in both nodes and breast. Histologic response was analyzed for each immunohistochemical subset. RESULTS: pCR was obtained for 53.4% of the patients. This pCR rate was higher in hormonal receptor negative (HER2 and triple negative) patients when compared to luminal tumours (69.7% vs 45.7%, p=0.023). DISCUSSION: The pCR rate found in this study is higher than those published in studies analyzing NACT (12.5%-27.1%). This can be explained by the combination of anthracycline and taxane, the use of trastuzumab when HER2 was overexpressed but also by RT associated to NACT. CONCLUSION: Inverting the sequence protocol for BC, requiring both CT and RT, allows more IBR without diminishing pCR and should therefore be considered as an acceptable therapeutic option.


Asunto(s)
Carcinoma de Mama in situ/terapia , Neoplasias de la Mama/terapia , Mamoplastia/métodos , Mastectomía Segmentaria/métodos , Terapia Neoadyuvante/métodos , Tratamientos Conservadores del Órgano/métodos , Adulto , Anciano , Antraciclinas/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma de Mama in situ/química , Carcinoma de Mama in situ/patología , Neoplasias de la Mama/química , Neoplasias de la Mama/patología , Hidrocarburos Aromáticos con Puentes/uso terapéutico , Quimioterapia Adyuvante , Supervivencia sin Enfermedad , Femenino , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Radioterapia Adyuvante , Receptor ErbB-2/análisis , Colgajos Quirúrgicos , Taxoides/uso terapéutico , Factores de Tiempo , Resultado del Tratamiento
2.
Ann Oncol ; 24(4): 1099-104, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23139262

RESUMEN

BACKGROUND: There is no proven benefit of adjuvant treatment of uterine sarcoma (US). SARCGYN phase III study compared adjuvant polychemotherapy followed by pelvic radiotherapy (RT) (arm A) versus RT alone (arm B) conducted to detect an increase ≥ 20% of 3-year PFS. METHODS: Patients with FIGO stage ≤ III US, physiological age ≤ 65 years; chemotherapy: four cycles of doxorubicin 50 mg/m² d1, ifosfamide 3 g/m²/day d1-2, cisplatin 75 mg/m² d3, (API) + G-CSF q 3 weeks. Study was stopped because of lack of recruitment. RESULTS: Eighty-one patients were included: 39 in arm A and 42 in arm B; 52 stage I, 16 stage II, 13 stage III; 53 leiomyosarcomas, 9 undifferenciated sarcomas, 19 carcinosarcomas. Gr 3-4 toxicity during API (/37 patients): thrombopenia (76%), febrile neutropenia (22%) with two toxic deaths; renal gr 3 (1 patient). After a median follow-up of 4.3 years, 41/81 patients recurred, 15 in arm A, 26 in arm B. The 3 years DFS is 55% in arm A, 41% in arm B (P = 0.048). The 3-year overall survival (OS) is 81% in arm A and 69% in arm B (P = 0.41). CONCLUSION: API adjuvant CT statistically increases the 3 year-DFS of patients with US.


Asunto(s)
Quimioterapia Adyuvante , Leiomiosarcoma/tratamiento farmacológico , Leiomiosarcoma/radioterapia , Sarcoma/tratamiento farmacológico , Sarcoma/radioterapia , Neoplasias Uterinas/tratamiento farmacológico , Neoplasias Uterinas/radioterapia , Adulto , Anciano , Cisplatino/administración & dosificación , Terapia Combinada , Supervivencia sin Enfermedad , Doxorrubicina/administración & dosificación , Femenino , Humanos , Ifosfamida/administración & dosificación , Estimación de Kaplan-Meier , Leiomiosarcoma/patología , Persona de Mediana Edad , Estadificación de Neoplasias , Sarcoma/patología , Neoplasias Uterinas/patología
3.
Artículo en Francés | MEDLINE | ID: mdl-7499745

RESUMEN

An unusual twin pregnancy was diagnosed echographically at 18 weeks gestation and confirmed by magnetic resonance imaging. One foetus was in a pseudo unicornis uterus and the other in a rudimentary uterus cornu. The risk in such cases, as also reported in the literature, is rupture of the rudimentary cornu at about 20 weeks gestation. In this case the patient was carefully monitored to 23 weeks when the pregnancy in the rudimentary cornu stopped spontaneously. The foetus in the pseudounicornis developed normally to 38 week term. This exceptional observation emphasizes the risk of pregnancy in a blind uterus cornu.


Asunto(s)
Embarazo Múltiple , Gemelos , Ultrasonografía Prenatal , Útero/anomalías , Adulto , Cesárea , Anomalías Congénitas/diagnóstico por imagen , Anomalías Congénitas/cirugía , Femenino , Humanos , Imagen por Resonancia Magnética , Embarazo , Resultado del Embarazo , Segundo Trimestre del Embarazo , Factores de Riesgo , Rotura Uterina/etiología
4.
Artículo en Francés | MEDLINE | ID: mdl-8051351

RESUMEN

We report a case of infantile polycystic kidney disease, during the course of two consecutive pregnancies in the same woman. Observed rates of recurrence in families at risk is higher than theoretical rates (25%). Antenatal ultrasound can show signs of bilateral involvement, which is always lethal and generally leads to elective termination of pregnancy. Diagnosis can rarely be made before 24 weeks of pregnancy.


Asunto(s)
Riñón Poliquístico Autosómico Recesivo , Aborto Terapéutico , Adulto , Biopsia , Diagnóstico Diferencial , Femenino , Asesoramiento Genético , Humanos , Riñón Poliquístico Autosómico Recesivo/congénito , Riñón Poliquístico Autosómico Recesivo/diagnóstico , Riñón Poliquístico Autosómico Recesivo/genética , Embarazo , Segundo Trimestre del Embarazo , Factores de Riesgo , Ultrasonografía Prenatal
5.
Artículo en Francés | MEDLINE | ID: mdl-8308204

RESUMEN

We report a case of giant fibroadenoma of the breast, "juvenile type", in a 15 year old girl. We study the characteristics of this tumor that occurs in adolescents females, the differential diagnosis with cystosarcoma phylloide and benign virginal hypertrophy, and treatment. Follow-up is recommended because of possible recurrent tumor of a short time.


Asunto(s)
Neoplasias de la Mama/diagnóstico , Fibroadenoma/diagnóstico , Adolescente , Cuidados Posteriores , Biopsia , Neoplasias de la Mama/cirugía , Diagnóstico Diferencial , Femenino , Fibroadenoma/cirugía , Humanos , Mamografía , Mastectomía Segmentaria , Ultrasonografía Mamaria
6.
Artículo en Francés | MEDLINE | ID: mdl-2019720

RESUMEN

We report a case of hyperestrogenisation which showed itself by the presence of a haematocolpometra in an elderly lady which could be attributed to prolonged and continuous treatment with Promestriene cream. Haematocolpometra is due to intra-uterine haemorrhage (itself due to hyperplastic endometrial polyps) with vaginal stenosis caused by vaginal atrophy that existed before local treatment was started. The Pomestriene is an estrogenic substance which works locally and does not seem to cause much in the way of general effects when used for short courses. If when it is used in large doses over a prolonged period of time, however, it is necessary to look for generalised hyperestrogenisation. Further studies are needed to confirm these finding.


Asunto(s)
Congéneres del Estradiol/efectos adversos , Estradiol/análogos & derivados , Hematocolpos/inducido químicamente , Hemorragia Uterina/inducido químicamente , Administración Tópica , Anciano , Anciano de 80 o más Años , Atrofia , Sobredosis de Droga , Estradiol/administración & dosificación , Estradiol/efectos adversos , Congéneres del Estradiol/administración & dosificación , Femenino , Humanos , Vagina/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...